Tweet this page
No longer registered as of 08 Mar 2018 - Registration as it was on 06 Mar 2017
How to read and use this data card.
Download this datacard


Lobbying Costs


Financial year: Apr 2016 - Mar 2017

Lobbyists (Full time equivalent)

0.25 Fte (1)

Lobbyists with EP accreditation


High-level Commission meetings


Lobbying Costs over the years

  • Info


    EU Transparency Register

    36101569520-87 First registered on 05 Sep 2012

    Goals / Remit

    BioMedima is a non-profit Association (Art. 60 ff. Swiss Civil law) that promotes the understanding and use of biomedical imaging in order to foster knowledge and technology transfer.

    BioMedima aims at becoming the main online gateway to
    worldwide resources in the field of biomedical imaging with four main goals:

    1)To educate by publishing an open-access comprehensive set of fundamental scientific
    information about biomedical imaging technologies and biophysics principle. On the BioMedima
    web site, the information is structured and presented in an innovative way to ease and fasten
    access and understanding.

    2)To reference by gathering in a database worldwide imaging actors (user & manufacturers), their
    expertise and related publications as well as their interactions (e.g. collaborations). Our database
    will use Web 3.0 semantic web technology for more efficient data organization and mining.

    3)To review by listing and commenting characteristics and uses of existing imaging scanners/
    machines, related IT tools and biochemical (contrast agents and molecular probes). Such a service
    does not exist at the moment but would be of great help to anyone interesting to invest in an
    imaging device or contrast medium.

    4)To synchronize by collecting and coordinating demands and offers for projects and
    collaborations in the field of biomedical imaging. BioMedima shall facilitate and link potential
    partners, take in charge administrative burden, ease the collaboration for sustainability and ensure
    good relations with other research or healthcare groups.

    Main EU files targeted



    Head Office
    Konradstrasse 14
    Zurich 8005
  • People

    Total lobbyists declared


    Employment timeLobbyists

    Lobbyists (Full time equivalent)


    Lobbyists with EP accreditation

    No lobbyists with EP accreditations

    Complementary Information

    Valentina Aureggi, PhD, co-founder, head of imaging chemistry: Valentina was born in Como (Italy) and studied Chemistry. She obtained her MSc. from the University
    of Neuchâtel (Switzerland) and her PhD in Organic Chemistry working at Novartis Pharma Basel in Process Research and Development in 2007 from the University of Neuchâtel. After two postdoctoral fellowships in Organic Chemistry (University of Toronto) and Medicinal Chemistry(ETH Zurich), Valentina works now in the consulting business.

    Cedric Berger, PhD and future MBA, founder and president:
    Cedric was born in Erlangen (Germany) and studied cell biology and biotechnologies in France; he obtained a MSc. Biomedical Imaging Technologies (ULP, France) and a PhD in Biophysics working at Novartis Discovery Technologies (Basel) from Basel University (Switzerland). Cedric spent
    more than two years as a postdoctoral fellow at Harvard Medical School and works now as a clinical science specialist in drug development for oncology indications.

    Antoine Leimgruber, MD, co-founder, head of cancer imaging:
    Antoine was born in Switzerland and was trained both as a physicist (MSc) and a physician (MD). Antoine's clinical training took place in Switzerland (research associate in molecular modeling at the Ludwig Institute for Cancer Research in Lausanne) and overseas from South America, the USA (postdoctoral fellow at the Center for Molecular Imaging Research in Harvard) and presently Australia.

    Moritz Wildgruber, MD PhD, co-founder, head of cardiovascular imaging: Moritz was born in Munich (Germany) and completed Medical School in Hamburg, Munich, New
    York and Bern. He obtained his thesis at the Interdisciplinary Center for Vascular Diseases at the
    Technische Universität München. He subsequently was a post-doctoral fellow at the Center for Molecular Imaging Research and Center for Systems Biology at Massachusetts General Hospital/ Harvard Medical School and act now as a radiologist at the Klinikum Rechts der Isar, Technische
    Universität München in Germany.

    Person in charge of EU relations

    Mr Cedric Berger (President)

    Person with legal responsibility

    Mr Cedric Berger (President)

  • Categories


    III - Non-governmental organisations


    Non-governmental organisations, platforms and networks and similar

  • Networking


    None declared

    Member organisations

    None declared

  • Financial Data

    Closed financial year

    Apr 2016 - Mar 2017

    Lobbying costs for closed financial year


    Other financial info

    No expenses except online maintenance of the web platform.

  • EU Structures

    Groups (European Commission)




    Groups (European Parliament)


    Other activities

    1) To build-up one central access point to global imaging resources: there is at the moment no easy way online
    to centrally access exhaustive information focusing on biomedical imaging. Expertise is clustered
    based on technology, information is provided in various formats, segmented and most of the time not presented in a clear and user-friendly way (to much advertisement, long text blocks, complex mathematical equations...).

    2) To develop and provide online tools to keep up with innovation pace: innovation in biomedical research is so fast that health professional (doctors, regulators, scientists...) already overwhelmed by their regular duties struggle to keep up with publication rate. There is a clear need to organize, present and diffuse new scientific
    information more efficiently.

    3) To support technology and knowledge transfer: while many new applications appear on the research
    side, very few efficiently translate into clinical routines or industrial applications. The laters
    lack time and resources to initiate and sustain constructive collaborations.

  • Meetings


    None declared

Download this datacard